ETFsMSCI Europe Equal Weighted Index
Invesco

Invesco MSCI Europe Equal Weight UCITS ETF Acc

MEEQ XETRAIrelandNot PEA-eligible
Last close · EUR
19.29EUR
-0.10% · -€0.02
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
MEEQBase
Fund charges
0.20%PRIIPs ongoing costs
Fund size
€275.2Mall share classes
Return 1Y
+15.6%
Sharpe 3Y
Not published
Volatility 1Y
12.0%annualised
Holdings
384Fund holdings

Performance

Compare
  • MEEQ+15.6%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
MEEQ+4.0%+1.3%+8.7%+13.4%+15.6%--
MSCI World+0.4%+4.9%+10.8%+16.0%+15.9%+75.5%+71.2%
Gap to MSCI World+3.6%-3.5%-2.1%-2.6%-0.2%--

Risk and return

Sharpe ratio · 1Y
1.13
Below MSCI World · 1.28
Return p.a.
+16.2%
Volatility
12.0%
Max loss
-9.0%Mar 2026

Sharpe vs indices

MSCI World
1.28
S&P 500
1.16
MEEQ
1.13
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
3.5%
Holdings
384
As of
Fund holdings
  1. 1GENMAB A/S DKK1DK00102722020.46%
  2. 2POSTE ITALIANE SPA EUR1IT00037961710.41%
  3. 3BIOMERIEUX NPVFR00132802860.33%
  4. 4DEMANT A/S DKK0.2DK00607385990.33%
  5. 5EUROFINS SCIENTIFIC EUR0.1FR0014000MR30.33%
  6. 6GIVAUDAN-REG CHF10CH00106459320.33%
  7. 7ORION OYJ-CLASS B EUR0.65FI00090143770.33%
  8. 8SARTORIUS AG-VORZUG EUR NPV PFDDE00071656310.33%
  9. 9SARTORIUS STEDIM BIOTECH EUR0.2FR00131540020.33%
  10. 10UCB SA NPVBE00037395300.33%

Countries

Classified 79.1%
Largest
14.7%United Kingdom
Top 3
39.1%
Effective number
12.51 / HHI

Market cap

Weight vs holdings

3.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.